Clinical Trial Update: tACS for Amyloid-β Reduction in Alzheimer's Disease [NA]

View source ↗

Summary

A completed clinical trial evaluating transcranial alternating current stimulation (tACS) for reduction of amyloid-β in Alzheimer's disease; results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• tACS

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Alzheimer Disease | NA | Status: COMPLETED | Results posted: 2022-03-03